ARTICLE | Clinical News
Gablofen baclofen regulatory update
December 6, 2010 8:00 AM UTC
FDA approved an NDA from CNS Therapeutics for Gablofen baclofen to manage severe spasticity. The application was submitted under section 505(b)(2) of the Food, Drug and Cosmetic Act, which allows spon...